Skip to main content
Normal View

Medicinal Products Licensing

Dáil Éireann Debate, Tuesday - 22 September 2015

Tuesday, 22 September 2015

Questions (790, 791)

Michael Healy-Rae

Question:

790. Deputy Michael Healy-Rae asked the Minister for Health the reason the drug roaccutane, that according to the Health Products Regulatory Authority records has caused at least three fatalities, numerous mental and physical health injuries is allowed maintain its licence and continue to be prescribed; and if he will make a statement on the matter. [30697/15]

View answer

Michael Healy-Rae

Question:

791. Deputy Michael Healy-Rae asked the Minister for Health if he is aware of the purpose for which the drug roaccutane was developed; if he has requested this information from a pharmaceutical company (details supplied); if any employees of the Health Products Regulatory Authority have knowledge of this; and if he will make a statement on the matter. [30698/15]

View answer

Written answers

I propose to take Questions Nos. 790 and 791 together.

I refer the Deputy to my composite reply 19166/15 of 19 May which provides a detailed reply to the questions asked by the Deputy.

Top
Share